The SafeBoosC phase II randomised clinical trial: A treatment guideline for targeted near-infrared-derived cerebral tissue oxygenation versus standard treatment in extremely preterm infants
- Adelina Pellicer
- , Gorm Greisen
- , Manon Benders
- , Olivier Claris
- , Eugene Dempsey
- , Monica Fumagalli
- , Christian Gluud
- , Cornelia Hagmann
- , Lena Hellström-Westas
- , Simon Hyttel-Sorensen
- , Petra Lemmers
- , Gunnar Naulaers
- , Gerhard Pichler
- , Claudia Roll
- , Frank Van Bel
- , Wim Van Oeveren
- , Maria Skoog
- , Martin Wolf
- , Topun Austin
- Hospital Universitario La Paz
- University of Copenhagen
- Utrecht University
- Hospices civils de Lyon
- IRCCS Fondazione Ca'Granda – Ospedale Maggiore Policlinico - Milano
- University of Zurich
- Uppsala University
- KU Leuven
- Medical University of Graz
- Vest Children's Hospital Datteln
- Haemoscan B.V.
- Cambridge University Hospitals NHS Foundation Trust
Research output: Contribution to journal › Article › peer-review